Skip to content
OpenCapital
Get started

Coya Therapeutics, Inc. COYA Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$3.6MBeat by $1.6M
EPS-$0.10Miss by $0.12
Revenue estimate$1.9M
EPS estimate$0.02

Next report

Aug 11, 2026 (In 2 weeks)
Revenue estimate$130.0K
EPS estimate-$0.36

Versus estimates

Revenue

Q1 2026$300.0KBeat by $150.0KQ4 2025$4.0MBeat by $1.8M
Q3 2025$3.6MBeat by $1.6M
Q2 2025$163.6KMiss by $619.7KQ1 2025$257.9KMiss by $2.4MQ4 2024$2.0KMiss by $98.0K

Diluted EPS

Q1 2026-$0.32Beat by $0.07Q4 2025-$0.34Miss by $0.07
Q3 2025-$0.10Miss by $0.12
Q2 2025-$0.36Miss by $0.14Q1 2025-$0.44In lineQ4 2024-$0.18Beat by $0.08

Ask the moment Coya Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Coya Therapeutics, Inc. report Q3 2025 earnings?
Coya Therapeutics, Inc. (COYA) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Coya Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Coya Therapeutics, Inc. reported revenue of $3.6M and eps of $-0.10 for Q3 2025.
Did Coya Therapeutics, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $1.9M by $1.6M. EPS missed the consensus estimate of $0.02 by $0.12.
How did Coya Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 61.5% from $-0.26.
Where can I find Coya Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-276022) and the 10-Q periodic report (0001193125-25-276058) directly on SEC EDGAR. The filing index links above go to sec.gov.